Celadon Pharmaceuticals Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • PIPE

  • Latest Deal Amount
  • $764K

  • Investors
  • 2

Celadon Pharmaceuticals General Information

Description

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis. It operates only in the UK and has only one geographical area.

Contact Information

Formerly Known As
VertiGrow, VertiGrow Technology
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 71-75 Shelton Street
  • London WC2H 9JQ
  • England, United Kingdom
+44 020
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 71-75 Shelton Street
  • London WC2H 9JQ
  • England, United Kingdom
+44 020

Celadon Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celadon Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. PIPE 15-Jul-2024 $764K Completed Generating Revenue
4. PIPE 12-Dec-2023 Completed Generating Revenue
3. PIPE 13-Oct-2023 Completed Generating Revenue
2. PIPE 25-Mar-2022 $11.2M $11.2M Completed Generating Revenue
1. Reverse Merger 25-Mar-2022 $106M Completed Generating Revenue
To view Celadon Pharmaceuticals’s complete valuation and funding history, request access »

Celadon Pharmaceuticals Patents

Celadon Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202417688-D0 Novel process Pending 02-Dec-2024

Celadon Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celadon Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Celadon Pharmaceuticals (Acquired in 2022) Corporation Minority
Seneca Partners (Haydock) Real Estate Minority
To view Celadon Pharmaceuticals’s complete investors history, request access »

Celadon Pharmaceuticals Investments & Acquisitions (3)

Celadon Pharmaceuticals’s most recent deal was a Early Stage VC with Kingdom Therapeutics for . The deal was made on 07-Jul-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Kingdom Therapeutics 07-Jul-2023 Early Stage VC Drug Discovery
Celadon Pharmaceuticals (Acquired in 2022) 25-Mar-2022 Merger/Acquisition Other Capital Markets/Institutions
Kingdom Therapeutics 07-Jun-2021 Seed Round Drug Discovery
To view Celadon Pharmaceuticals’s complete investments and acquisitions history, request access »

Celadon Pharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Food Products

Industry

Rank

Percentile

Agriculture

Subindustry

Rank

Percentile

To view Celadon Pharmaceuticals’s complete esg history, request access »

Celadon Pharmaceuticals FAQs

  • When was Celadon Pharmaceuticals founded?

    Celadon Pharmaceuticals was founded in 2018.

  • Where is Celadon Pharmaceuticals headquartered?

    Celadon Pharmaceuticals is headquartered in London, United Kingdom.

  • What is the size of Celadon Pharmaceuticals?

    Celadon Pharmaceuticals has 19 total employees.

  • What industry is Celadon Pharmaceuticals in?

    Celadon Pharmaceuticals’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Celadon Pharmaceuticals a private or public company?

    Celadon Pharmaceuticals is a Private company.

  • What is Celadon Pharmaceuticals’s current revenue?

    The current revenue for Celadon Pharmaceuticals is .

  • How much funding has Celadon Pharmaceuticals raised over time?

    Celadon Pharmaceuticals has raised $15.7M.

  • Who are Celadon Pharmaceuticals’s investors?

    Celadon Pharmaceuticals (Acquired in 2022) and Seneca Partners (Haydock) have invested in Celadon Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process